D
Theravance Biopharma, Inc. TBPH
$8.77 -$0.24-2.66%
Recommendation
Sell
Prev Close
$9.01
Volume
213,671
Avg Vol (90D)
221,573
Market Cap
$445.73M
Dividend & Yield
--
52-Week Range
$7.44 - $10.90
P/E (TTM)
--
EPS (TTM)
-$1.15
My Lists My Alerts
Rating
Reward
E
Very Weak
Risk
D
Weak
Rating Factors
Growth Index
Fair
Efficiency Index
Very Weak
Solvency Index
Excellent
Total Return Index
Weak
Volatility Index
Fair
Dividend Index
--
Headlines
Theravance Biopharma (TBPH, $8.93) Stochastic Oscillator left the oversold zone on March 31, 2025
4/1/2025 - Tickeron - Stocks
Theravance Biopharma (TBPH) Shares Cross Below 200 DMA
3/31/2025 - Market News Video
Theravance Biopharma to Participate in an Upcoming Investor Conference
3/31/2025 - GuruFocus
Theravance Biopharma to Participate in an Upcoming Investor Conference
3/31/2025 - PR Newswire
Why Is Theravance Bio (TBPH) Up 0.4% Since Last Earnings Report?
3/28/2025 - Zacks Investment Research
Theravance Biopharma to Present New Ampreloxetine Analyses in Neurogenic Orthostatic ...
3/27/2025 - GuruFocus
Theravance Biopharma to Present New Ampreloxetine Analyses in Neurogenic Orthostatic Hypotension (nOH) at the 77th Annual Meeting of the American Academy of Neurology
3/27/2025 - PR Newswire
Theravance Biopharma (TBPH, $9.31) Moving Average Convergence Divergence (MACD) Histogram turned negative on March 25, 2025
3/26/2025 - Tickeron - Stocks
Theravance Biopharma (TBPH, $9.31) price exceeded its 50-day Moving Average on March 25, 2025
3/26/2025 - Tickeron - Stocks
Q1 EPS Forecast for Theravance Biopharma Reduced by Analyst
3/24/2025 - MarketBeat
Theravance Biopharma (TBPH, $9.36) Moving Average Convergence Divergence (MACD) Histogram turned positive on March 20, 2025
3/21/2025 - Tickeron - Stocks
Theravance Biopharma (TBPH, $9.47) Stochastic Oscillator left the oversold zone on March 19, 2025
3/20/2025 - Tickeron - Stocks
Theravance Biopharma (TBPH, $9.47) price moved above its 50-day Moving Average on March 19, 2025
3/20/2025 - Tickeron - Stocks
Theravance Biopharma (NASDAQ:TBPH) Stock Passes Above Fifty Day Moving Average - Should You Sell?
3/19/2025 - Ticker Report
Theravance Biopharma (TBPH, $9.21) price exceeded its 50-day Moving Average on March 18, 2025
3/19/2025 - Tickeron - Stocks
Theravance Biopharma (TBPH, $9.21) Stochastic Oscillator left the oversold zone on March 18, 2025
3/19/2025 - Tickeron - Stocks
Theravance Biopharma (TBPH, $9.35) price moved above its 50-day Moving Average on March 17, 2025
3/18/2025 - Tickeron - Stocks
Theravance Biopharma (TBPH, $9.23) Moving Average Convergence Divergence (MACD) Histogram turned negative on March 14, 2025
3/15/2025 - Tickeron - Stocks
Theravance Biopharma (TBPH, $9.28) price exceeded its 50-day Moving Average on March 13, 2025
3/14/2025 - Tickeron - Stocks
Theravance Biopharma (TBPH, $9.44) price moved above its 50-day Moving Average on March 12, 2025
3/13/2025 - Tickeron - Stocks
Theravance Biopharma (TBPH, $9.29) price exceeded its 50-day Moving Average on March 11, 2025
3/12/2025 - Tickeron - Stocks
Theravance Biopharma: Clinical Progress Is Not Enough To Make It Attractive
3/10/2025 - SeekingAlpha
Theravance Biopharma (TBPH, $9.72) price moved above its 50-day Moving Average on March 05, 2025
3/6/2025 - Tickeron - Stocks
Theravance Biopharma (TBPH, $9.72) Moving Average Convergence Divergence (MACD) Histogram turned positive on March 5, 2025
3/6/2025 - Tickeron - Stocks
Theravance Biopharma (TBPH, $9.72) price moved above its 50-day Moving Average on March 05, 2025
3/6/2025 - Tickeron - Stocks
Income Statement
Total Revenue (TTM)
$64.38M
EBITDA (TTM)
-$40.73M
EBIT (TTM)
-$42.44M
Net Income (TTM)
-$56.42M
Balance Sheet
Total Assets (Q)
$354.16M
Total Debt (Q)
$49.82M
Total Liabilities (Q)
$178.62M
Book Value Per Share (Q)
$3.55
Cash Flow
Cash from Operations (TTM)
-$11.54M
Cash from Investing (TTM)
$12.28M
Cash from Financing (TTM)
-$2.50M
Net Change in Cash (TTM)
-$1.75M
Filings
Filing Date
Friday, March 7, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 12 and 16 (est)
Price History
Loading...
Beta
0.67
7-Day Total Return
-5.80%
30-Day Total Return
-9.21%
60-Day Total Return
-4.57%
90-Day Total Return
-12.04%
Year to Date Total Return
-5.50%
1-Year Total Return
-5.60%
2-Year Total Return
-22.11%
3-Year Total Return
-7.68%
5-Year Total Return
-61.60%
52-week Low
Aug 09, 2024 - $7.44
52-week High
Jan 24, 2025 - $10.90
Valuation
Market Cap
$445.73M - Small Cap
Enterprise Value
$407.20M
Price/Sales (TTM)
6.90
Price/Book (Q)
2.54
Dividends and Shares
Shares Outstanding
49.31M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.theravance.com
Phone Number
650 808 6000
Address
901 Gateway Boulevard
South San Francisco, CA 94080
Country
United States
Year Founded
2013
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Theravance Biopharma, Inc., a biopharmaceutical company develops, and commercializes of medicines in the United States and Europe. It offers YUPELRI, a once-daily, nebulized long-acting... more
NASDAQ 04/03/2025 4:00PM Eastern Quotes delayed
Weiss Ratings